The Lloyds share price is up 15% this week! Should I buy more for my ISA right now?

Jonathan Smith argues that the Lloyds share price rally is due to the vaccine news, but would hold off buying for the moment until there’s more details.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’ve owned shares in Lloyds Banking Group (LSE: LLOY) for years. I’ve bought and sold along the way, with my current average buy-in price around 35p. It’s been a tough year so far for the Lloyds share price. It sits down around 50% year-to-date. This week has been much better, shown by the share price jumping up close to 32p, in a 15% gain at the time of writing. 

With large short-term gains like this, there’s always the thought to buy more and add it to my Stocks and Shares ISA right now. This move could have plenty of upside left, something that would really lift my overall portfolio performance for this year. Buying it within my ISA allows me to benefit from any potential profit, without losing any to capital gains tax obligations. But what’s the fundamental driver for the share price here?

The Biden bounce and vaccine news

Stock markets around the world had a double dose of good news as we started the week. Firstly, Joe Biden passed the threshold of votes needed to ensure he will become the next President of the United States. This was taken as a positive, with stocks rallying in the aftermath. Added to this was the surprise announcement that the vaccine Pfizer has been jointly working on has seen a 90% effectiveness during recent trials. This is a logical boost for most companies that have been negatively impacted since the start of the virus.

We’ve seen different share price moves depending on the size of the benefit each firm individually has to the above news. For example, I wrote yesterday how Rolls-Royce and IAG both rallied over 35%. The Lloyds share price didn’t rally as much, but is still in double figures for the week so far. 

The Biden bounce was good news for Lloyds from the point of view that global uncertainty and risk from the US election has been taken away. This is more of a general premise that has seen stocks rise, and isn’t company-specific to Lloyds. The vaccine news is more of the driver for the move higher. The knock on impact of a vaccine should be higher consumer spending as businesses reopen. It’ll also support higher business spending, reduction in bad debt provisions, and higher interest rates in the longer term. All of these things are good news for the bank, hence the share price move upwards.

Could the Lloyds share price go even higher?

From my point of view, it’s a little bit too early for me to jump in again and buy more. I fear some investors may have got a little ahead of themselves on the vaccine news. I definitely think there will be a good time to buy into Lloyds before the end of the year, but I’d like to see a little more detail about the vaccine. How quickly will it be available in the UK? How much will be available? Questions like these will determine where the Lloyds share price goes from here.

jonathansmith1 owns shares in Lloyds Banking Group. The Motley Fool UK has recommended Lloyds Banking Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »